Better Therapeutics (BTTX) Institutional Ownership → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free BTTX Stock Alerts $0.01 +0.00 (+11.11%) (As of 03:53 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Better Therapeutics (NASDAQ:BTTX)CurrentInstitutional OwnershipPercentage34.00%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$579.41KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$319.39K Get BTTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Better Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BTTX Institutional Buying and Selling by Quarter Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. Better Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2024MMCAP International Inc. SPC356,270$65K0.0%-77.5%0.715% 11/14/2023MMCAP International Inc. SPC1,583,079$579K0.2%N/A3.340% 5/15/2023Farallon Capital Management LLC699,042$509K0.0%-14.1%2.931% 5/10/2022Sectoral Asset Management Inc.878,531$1.74M0.3%-9.8%3.721% 5/4/2022Victory Capital Management Inc.272,720$540K0.0%N/A1.155% (Data available from 1/1/2016 forward) BTTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BTTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Better Therapeutics shares: Sectoral Asset Management Inc. ($1.74M), Victory Capital Management Inc. ($540K), and Farallon Capital Management LLC ($509K), MMCAP International Inc. SPC ($65K).Learn more on BTTX's institutional investors. What percentage of Better Therapeutics stock is owned by institutional investors? 34.00% of Better Therapeutics stock is owned by institutional investors. Learn more on BTTX's institutional investor holdings. Which institutional investors have been buying Better Therapeutics stock? The following institutional investors have purchased Better Therapeutics stock in the last 24 months: MMCAP International Inc. SPC ($1.58M), and Victory Capital Management Inc. ($272.72K). How much institutional buying is happening at Better Therapeutics? Institutional investors have bought a total of 1,855,799 shares in the last 24 months. This purchase volume represents approximately $1.12M in transactions. Which Better Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Better Therapeutics stock in the last 24 months: MMCAP International Inc. SPC ($1.23M), Farallon Capital Management LLC ($114.51K), and Sectoral Asset Management Inc. ($95.30K). How much institutional selling is happening at Better Therapeutics? Institutional investors have sold a total of 1,436,625 shares in the last 24 months. This volume of shares sold represents approximately $508.09K in transactions. Related Companies: MOTS Major Shareholders SINT Major Shareholders ALLR Major Shareholders NVTA Major Shareholders ADTX Major Shareholders AMPE Major Shareholders APVO Major Shareholders SMFL Major Shareholders ATHX Major Shareholders BLPH Major Shareholders This page (NASDAQ:BTTX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
